DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
75.24
+0.36 (0.48%)
At close: Nov 20, 2024, 4:00 PM
75.00
-0.24 (-0.32%)
After-hours: Nov 20, 2024, 7:59 PM EST

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of $29.39 billion. The enterprise value is $29.49 billion.

Market Cap 29.39B
Enterprise Value 29.49B

Important Dates

The last earnings date was Thursday, October 24, 2024, after market close.

Earnings Date Oct 24, 2024
Ex-Dividend Date n/a

Share Statistics

DexCom has 390.60 million shares outstanding. The number of shares has decreased by -2.90% in one year.

Current Share Class 390.60M
Shares Outstanding 390.60M
Shares Change (YoY) -2.90%
Shares Change (QoQ) -1.58%
Owned by Insiders (%) 0.41%
Owned by Institutions (%) 96.46%
Float 387.47M

Valuation Ratios

The trailing PE ratio is 45.12 and the forward PE ratio is 38.87. DexCom's PEG ratio is 1.57.

PE Ratio 45.12
Forward PE 38.87
PS Ratio 7.46
Forward PS 6.00
PB Ratio 14.85
P/TBV Ratio 15.89
P/FCF Ratio 54.93
P/OCF Ratio 35.77
PEG Ratio 1.57
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.09, with an EV/FCF ratio of 55.12.

EV / Earnings 43.31
EV / Sales 7.46
EV / EBITDA 35.09
EV / EBIT 46.95
EV / FCF 55.12

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 1.31.

Current Ratio 2.46
Quick Ratio 2.03
Debt / Equity 1.31
Debt / EBITDA 2.97
Debt / FCF 4.84
Interest Coverage 33.05

Financial Efficiency

Return on equity (ROE) is 32.06% and return on invested capital (ROIC) is 8.21%.

Return on Equity (ROE) 32.06%
Return on Assets (ROA) 6.06%
Return on Capital (ROIC) 8.21%
Revenue Per Employee $411,875
Profits Per Employee $70,917
Employee Count 9,600
Asset Turnover 0.61
Inventory Turnover 2.60

Taxes

In the past 12 months, DexCom has paid $63.10 million in taxes.

Income Tax 63.10M
Effective Tax Rate 8.48%

Stock Price Statistics

The stock price has decreased by -28.32% in the last 52 weeks. The beta is 1.17, so DexCom's price volatility has been higher than the market average.

Beta (5Y) 1.17
52-Week Price Change -28.32%
50-Day Moving Average 70.43
200-Day Moving Average 101.95
Relative Strength Index (RSI) 60.39
Average Volume (20 Days) 4,998,164

Short Selling Information

The latest short interest is 9.36 million, so 2.40% of the outstanding shares have been sold short.

Short Interest 9.36M
Short Previous Month 7.68M
Short % of Shares Out 2.40%
Short % of Float 2.42%
Short Ratio (days to cover) 1.97

Income Statement

In the last 12 months, DexCom had revenue of $3.95 billion and earned $680.80 million in profits. Earnings per share was $1.67.

Revenue 3.95B
Gross Profit 2.44B
Operating Income 628.00M
Pretax Income 806.90M
Net Income 680.80M
EBITDA 840.40M
EBIT 628.00M
Earnings Per Share (EPS) $1.67
Full Income Statement

Balance Sheet

The company has $2.49 billion in cash and $2.59 billion in debt, giving a net cash position of -$98.90 million or -$0.25 per share.

Cash & Cash Equivalents 2.49B
Total Debt 2.59B
Net Cash -98.90M
Net Cash Per Share -$0.25
Equity (Book Value) 1.98B
Book Value Per Share 5.07
Working Capital 2.53B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $821.70 million and capital expenditures -$286.70 million, giving a free cash flow of $535.00 million.

Operating Cash Flow 821.70M
Capital Expenditures -286.70M
Free Cash Flow 535.00M
FCF Per Share $1.37
Full Cash Flow Statement

Margins

Gross margin is 61.68%, with operating and profit margins of 15.88% and 17.22%.

Gross Margin 61.68%
Operating Margin 15.88%
Pretax Margin 18.81%
Profit Margin 17.22%
EBITDA Margin 21.25%
EBIT Margin 15.88%
FCF Margin 16.91%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 2.90%
Shareholder Yield 2.90%
Earnings Yield 2.32%
FCF Yield 1.82%
Dividend Details

Analyst Forecast

The average price target for DexCom is $101.29, which is 34.62% higher than the current price. The consensus rating is "Buy".

Price Target $101.29
Price Target Difference 34.62%
Analyst Consensus Buy
Analyst Count 17
Revenue Growth Forecast (5Y) 17.38%
EPS Growth Forecast (5Y) 25.32%
Stock Forecasts

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Jun 13, 2022
Split Type Forward
Split Ratio 4:1

Scores

DexCom has an Altman Z-Score of 7.59 and a Piotroski F-Score of 5.

Altman Z-Score 7.59
Piotroski F-Score 5